A detailed history of Clifford Swan Investment Counsel LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Clifford Swan Investment Counsel LLC holds 5,260 shares of LLY stock, worth $4.15 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,260
Previous 5,001 5.18%
Holding current value
$4.15 Million
Previous $4.53 Million 2.94%
% of portfolio
0.17%
Previous 0.17%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $199,984 - $248,645
259 Added 5.18%
5,260 $4.66 Million
Q2 2024

Aug 06, 2024

SELL
$724.87 - $909.04 $23,195 - $29,089
-32 Reduced 0.64%
5,001 $4.53 Million
Q1 2024

Apr 16, 2024

SELL
$592.2 - $792.28 $30,202 - $40,406
-51 Reduced 1.0%
5,033 $3.92 Million
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $130,247 - $153,544
-248 Reduced 4.65%
5,084 $2.96 Million
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $7,824 - $10,787
18 Added 0.34%
5,332 $2.86 Million
Q2 2023

Aug 03, 2023

BUY
$350.74 - $468.98 $205,182 - $274,353
585 Added 12.37%
5,314 $2.49 Million
Q1 2023

May 05, 2023

SELL
$310.63 - $364.82 $125,183 - $147,022
-403 Reduced 7.85%
4,729 $1.62 Million
Q4 2022

Feb 02, 2023

SELL
$321.55 - $374.67 $5,787 - $6,744
-18 Reduced 0.35%
5,132 $1.88 Million
Q2 2022

Aug 04, 2022

BUY
$278.73 - $327.27 $18,396 - $21,599
66 Added 1.3%
5,150 $1.67 Million
Q1 2022

May 03, 2022

SELL
$234.69 - $291.66 $35,203 - $43,749
-150 Reduced 2.87%
5,084 $1.46 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $15,739 - $19,532
-70 Reduced 1.32%
5,234 $1.45 Million
Q3 2021

Nov 02, 2021

BUY
$221.6 - $272.71 $44,320 - $54,541
200 Added 3.92%
5,304 $1.23 Million
Q2 2021

Aug 05, 2021

SELL
$180.55 - $233.54 $4,513 - $5,838
-25 Reduced 0.49%
5,104 $1.34 Million
Q1 2021

May 07, 2021

SELL
$164.32 - $212.72 $4,108 - $5,318
-25 Reduced 0.49%
5,129 $958,000
Q4 2020

Feb 11, 2021

SELL
$130.46 - $172.63 $9,914 - $13,119
-76 Reduced 1.45%
5,154 $870,000
Q3 2020

Oct 30, 2020

BUY
$146.22 - $169.13 $146 - $169
1 Added 0.02%
5,230 $774,000
Q2 2020

Aug 06, 2020

SELL
$136.42 - $164.18 $8,185 - $9,850
-60 Reduced 1.13%
5,229 $858,000
Q1 2020

Apr 09, 2020

BUY
$119.05 - $147.35 $8,333 - $10,314
70 Added 1.34%
5,289 $734,000
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $33,347 - $38,925
-301 Reduced 5.45%
5,219 $578,000
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $144,703 - $170,326
-1,300 Reduced 19.06%
5,520 $716,000
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $2,647 - $2,966
-25 Reduced 0.37%
6,820 $789,000
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $44,647 - $55,801
-520 Reduced 7.06%
6,845 $735,000
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $49,583 - $56,906
-655 Reduced 8.17%
7,365 $628,000
Q1 2018

May 09, 2018

SELL
$74.21 - $87.6 $26,715 - $31,535
-360 Reduced 4.3%
8,020 $621,000
Q4 2017

Feb 09, 2018

BUY
$81.94 - $87.89 $81,940 - $87,890
1,000 Added 13.55%
8,380 $708,000
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $14,643 - $16,252
190 Added 2.64%
7,380 $631,000
Q2 2017

Aug 11, 2017

BUY
N/A
7,190
7,190 $592,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Clifford Swan Investment Counsel LLC Portfolio

Follow Clifford Swan Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.